Clinical Trial Update: Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of cyclophosphamide and sirolimus for metastatic, radioiodine-refractory differentiated thyroid cancer. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Rapamune (sirolimus)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Metastatic Thyroid Cancer | Phase 2 | Status: RECRUITING